ID   HU-3
AC   CVCL_A619
DR   Cosmic; 787436
DR   Cosmic; 975255
DR   Cosmic; 1012070
DR   Cosmic; 1281318
DR   Cosmic; 2306210
DR   Wikidata; Q54896687
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
RX   PubMed=9406997;
RX   PubMed=16408098;
CC   Characteristics: CSF2 dependent.
CC   Doubling time: 60 +- 11 hours (PubMed=9096695).
CC   Derived from sampling site: Bone marrow.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 12-03-20; Version: 8
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
RX   PubMed=9096695; DOI=10.1038/sj.leu.2400621;
RA   Drexler H.G., Zaborski M., Quentmeier H.;
RT   "Thrombopoietin supports the continuous growth of cytokine-dependent
RT   human leukemia cell lines.";
RL   Leukemia 11:541-551(1997).
RX   PubMed=9406997;
RA   Morgan D.A., Class R., Soslau G., Brodsky I.;
RT   "Cytokine-mediated erythroid maturation in megakaryoblastic human cell
RT   line HU-3.";
RL   Exp. Hematol. 25:1378-1385(1997).
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.;
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).